Inbiose NV, based in Ghent, Belgium, specializes in the research, development, and production of specialty carbohydrates, particularly Human Milk Oligosaccharides (HMOs). Utilizing its GlycoActives technology platform, the company focuses on cost-effective processes for large-scale production of complex carbohydrates, catering to both human and animal health markets. Inbiose offers a diverse range of products, including infant nutrition solutions, probiotics, and nutraceuticals, aimed at enhancing immune defenses, brain development, and gastrointestinal health. Their product line features various specialty carbohydrates like L-fucose and L-ribose, alongside human milk bioactives for food formulations and dietary supplements. Additionally, Inbiose engages in biological feasibility studies, fermentation protocol development, and process optimization, serving a wide array of industries, including biomedical and agro sectors. The company collaborates with various partners in scientific, life sciences, and industrial fields through licensing, co-development, and manufacturing contracts. Established in 2013, Inbiose is committed to advancing the production of specialty carbohydrates for health applications.